Grace Therapeutics Inc (GRCE)
3.125
+0.02
(+0.81%)
USD |
NASDAQ |
Oct 31, 16:00
3.15
+0.02
(+0.80%)
After-Hours: 20:00
Grace Therapeutics Max Drawdown (5Y): 98.73% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 98.73% |
| September 30, 2024 | 98.73% |
| August 31, 2024 | 98.73% |
| July 31, 2024 | 98.73% |
| June 30, 2024 | 98.73% |
| May 31, 2024 | 98.73% |
| April 30, 2024 | 98.73% |
| March 31, 2024 | 98.73% |
| February 29, 2024 | 98.73% |
| January 31, 2024 | 98.73% |
| December 31, 2023 | 98.73% |
| November 30, 2023 | 98.73% |
| October 31, 2023 | 98.73% |
| September 30, 2023 | 98.73% |
| August 31, 2023 | 98.55% |
| July 31, 2023 | 98.52% |
| June 30, 2023 | 98.52% |
| May 31, 2023 | 98.52% |
| April 30, 2023 | 98.52% |
| March 31, 2023 | 98.52% |
| February 28, 2023 | 98.52% |
| January 31, 2023 | 98.52% |
| December 31, 2022 | 98.52% |
| November 30, 2022 | 98.45% |
| October 31, 2022 | 98.45% |
| Date | Value |
|---|---|
| September 30, 2022 | 98.45% |
| August 31, 2022 | 98.45% |
| July 31, 2022 | 98.45% |
| June 30, 2022 | 98.45% |
| May 31, 2022 | 98.45% |
| April 30, 2022 | 98.45% |
| March 31, 2022 | 98.45% |
| February 28, 2022 | 98.45% |
| January 31, 2022 | 98.45% |
| December 31, 2021 | 98.45% |
| November 30, 2021 | 98.45% |
| October 31, 2021 | 98.45% |
| September 30, 2021 | 98.45% |
| August 31, 2021 | 98.45% |
| July 31, 2021 | 98.45% |
| June 30, 2021 | 98.45% |
| May 31, 2021 | 98.45% |
| April 30, 2021 | 98.45% |
| March 31, 2021 | 98.45% |
| February 28, 2021 | 98.45% |
| January 31, 2021 | 98.45% |
| December 31, 2020 | 98.45% |
| November 30, 2020 | 98.45% |
| October 31, 2020 | 98.45% |
| September 30, 2020 | 98.45% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
98.45%
Minimum
Nov 2019
98.73%
Maximum
Sep 2023
98.53%
Average
98.45%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
| Aurinia Pharmaceuticals Inc | 87.58% |
| Edesa Biotech Inc | 99.58% |
| Lexaria Bioscience Corp | 98.90% |
| Xenon Pharmaceuticals Inc | 54.01% |
| ESSA Pharma Inc | 98.68% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -70.55 |
| Beta (5Y) | 1.506 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 116.3% |
| Historical Sharpe Ratio (5Y) | -0.4393 |
| Historical Sortino (5Y) | -0.8812 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.47% |